AMICUS THERAPEUTICS, INC. — Investor Presentation 2016

Sep 14, 2016

*UNITED STATES*

*SECURITIES AND EXCHANGE COMMISSION*

*WASHINGTON, D.C. 20549*

*FORM 8-K*

*CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934*

Date of Report (Date of earliest event reported): September 14, 2016

*AMICUS THERAPEUTICS, INC.*

(Exact Name of Registrant as Specified in Its Charter)

*Delaware*

(State or Other Jurisdiction of Incorporation)

001-33497	71-0869350
(Commission File Number)	(IRS Employer Identification No.)

1 Cedar Brook Drive, Cranbury, NJ	08512
(Address of Principal Executive Offices)	(Zip Code)

Registrant’s telephone number, including area code: (609) 662-2000

(Former Name or Former Address, if Changed Since Last Report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

SEQ.=1,FOLIO='',FILE='C:\JMS\108224\16-18491-1\task8098890\18491-1-ba.htm',USER='108224',CD='Sep 14 04:03 2016'

*Item 8.01. Other Events.*

The senior management of Amicus Therapeutics, Inc. (the “Company”) is using the presentation attached as Exhibit 99.1 to this Current Report in its current meetings with investors and analysts.

*Item 9.01. Financial Statements and Exhibits.*

(d) Exhibits: The Exhibit Index annexed hereto is incorporated herein by reference.

2

SEQ.=1,FOLIO='2',FILE='C:\JMS\108224\16-18491-1\task8098890\18491-1-ba.htm',USER='108224',CD='Sep 14 04:03 2016'

*SIGNATURES*

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

/s/ ELLEN S. ROSENBERG
Ellen S. Rosenberg
General Counsel and Corporate Secretary

3

SEQ.=1,FOLIO='3',FILE='C:\JMS\108224\16-18491-1\task8098890\18491-1-ba.htm',USER='108224',CD='Sep 14 04:03 2016'

*EXHIBIT INDEX*

Exhibit No.	Description
99.1	Presentation Materials

4

SEQ.=1,FOLIO='4',FILE='C:\JMS\108224\16-18491-1\task8098890\18491-1-ba.htm',USER='108224',CD='Sep 14 04:03 2016'